Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov

Table 1.17
Patients with breast cancer who received recommended treatment: axillary node dissection or sentinel lymph node biopsy at the time of surgery (lumpectomy or mastectomy) for women with Stage I-IIB breast cancera, United States, 1999 and 2004
Population group 2004 1999
Percent Standard error Percent Standard error
Total   85.0 0.2 75.3 0.2
Node Dissection Sentinel lymph node biopsy 30.0 0.3 12.9 0.2
Axillary node dissection 36.5 0.3 48.7 0.2
Combination 18.5 0.2 13.7 0.2
Age Under age 40 89.0 0.7 85.3 0.7
40-49 89.9 0.4 85.0 0.4
50-59 90.2 0.3 85.1 0.4
60-69 89.4 0.4 82.6 0.4
70-79 83.2 0.5 69.1 0.5
80 and over 56.5 0.9 37.2 0.7
Race American Indian/Alaska Native DSU DSU DSU DSU
Asian 87.2 1.1 83.1 1.2
Hawaiian Pacific Islander DSU DSU DSU DSU
Black only 84.6 0.6 77.0 0.7
White only 85.0 0.2 75.1 0.2
Ethnicity Hispanic, all races 85.7 0.8 81.3 1.0
Non-Hispanic, other 86.8 1.1 82.7 1.2
Non-Hispanic, Black 85.0 0.7 77.0 0.7
Non-Hispanic, White 84.8 0.2 74.7 0.2
Health insurance, under age 65 Private 88.9 0.3 81.7 0.3
Public only 79.2 0.4 65.4 0.4
Uninsured/other 87.4 0.4 82.4 0.3
Health insurance, age 65 and over Medicare only 76.7 0.9 62.4 0.7
Medicare and supplement 76.7 0.5 62.6 0.5
Family incomeb Negative/poor 79.6 3.5 67.7 3.3
Near poor/low 85.0 0.2 76.1 0.3
Middle 84.5 0.4 73.4 0.4
High 85.1 1.1 73.3 1.2
Residence location Fringe metro, more than 1 million 83.8 0.3 73.3 0.3
Metro, 0.25-1 million 86.2 0.4 75.4 0.5
Metro, less than 0.25 million 87.0 0.6 79.0 0.6
Non-metro, urban 86.2 0.5 80.4 0.6
Completely rural 87.9 1.4 82.8 1.5
Residence location Metropolitan 84.7 0.2 74.5 0.2
Large metropolitan, more than 1 million 83.8 0.3 73.3 0.3
Small metropolitan, less than 1 million 86.4 0.4 76.5 0.4
Micropolitan 85.7 0.7 81.2 0.7
Noncore 87.4 0.8 79.9 0.8
Noncore, adjacent 86.5 0.9 79.0 0.9
Noncore, rural 90.2 1.4 83.2 1.6

a There is not full agreement regarding the appropriate population (denominator) for this measure, addressing lymph node surgery in women with breast cancer. In the most current draft form during production of the Reports, the measure specification from the National Quality Forum included only women with stage I/II cancer. Women classified as having stage III disease during lymph node surgery (based on 4 or more positive nodes) will be excluded if their stage prior to surgery (i.e., clinical stage) was not recorded. This may artificially lower the rates for this measure.

b Negative/poor refers to household incomes below $17,500; near poor/low, over the poverty line to just below 200 percent of the Federal poverty line; middle, 200 percent to just below 400 percent of the poverty line; and high, 400 percent of the poverty line and over.

DSU - Data do not meet the criteria for statistical reliability, data quality, or confidentiality.

Source: Commission on Cancer, American College of Surgeons and American Cancer Society, National Cancer Data Base.

 

AHRQ Advancing Excellence in Health Care